Versant Capital Management, Inc Biolife Solutions Inc Transaction History

Versant Capital Management, Inc

  • $454 Million
  • Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 96 shares of BLFS stock, worth $2,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 81 18.52%
Holding current value
$2,505
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025
BUY
$20.47 - $27.47 $307 - $412
15 Added 18.52%
96 $2,000
Q3 2024

Oct 07, 2024
BUY
$19.19 - $26.52 $1,554 - $2,148
81 New
81 $2,000

Others Institutions Holding BLFS

# of Institutions
189
Shares Held
46.1M
Call Options Held
8.2K
Put Options Held
4K
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.11B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email